02:38Why The HIV Vaccine Is Closer Than Ever
From the creator
Scientists are hopeful that the mRNA technology used in the Moderna and Pfizer-BioNTech Covid vaccines could be a turning point in HIV vaccine development. Watch the video above to learn why mRNA technology seems so promising, how this research is funded and who ultimately makes the money once a vaccine is ready to go to market. 0:00 - Introduction 2:02 - Funding research 4:28 - mRNA vaccines 8:20 - Ownership and profit 10:56 - Access Every Dec. 1, the world commemorates those who have died from an AIDS-related illness. Known as World AIDS Day, it serves as a reminder that there has been an ongoing pandemic for the past 40 years, pre-dating Covid. The Covid vaccines were sequenced, developed and approved in the U.S. in record time, but that would not have been possible without decades of work by HIV researchers. “Almost everybody working on Covid vaccines comes from the HIV world,” said Mitchell Warren, executive director of AVAC, a global advocacy group for HIV prevention. “Moderna had been working on mRNA-based HIV vaccine before SARS-CoV-2 was even known to exist.” An HIV vaccine has eluded scientists for decades. The traditional thinking around vaccines is to mimic the body’s natural immune response to a virus. The problem with HIV is the body’s natural immune response isn’t strong enough to fight the virus. This means a vaccine has to come at the problem in a different way. Scientists are hopeful that mRNA technology — the same technology used in the Covid vaccines
Published 2021-12-01 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.
Keep exploring News
02:38
02:38
02:06‘Trump’s exit strategy may depend on quietly lifting Iran blockade’ | AJ #shorts
Al Jazeera English
05:26Israeli attacks kill two Palestinians in Gaza as ceasefire violations continue
Al Jazeera English
06:29Brief: Israel's launches first ground operation in Gaza since ceasefire | The Take
Al Jazeera English
01:40
02:02